Loading...
Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patients
BACKGROUND: Gliomas are the most frequently occurring malignant brain cancers. Recently, isocitrate dehydrogenase (IDH) mutations, O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and 1p/19q co-deletion have been suggested to indicate a favorable prognosis in gliomas. However, the...
Na minha lista:
| Udgivet i: | Ann Transl Med |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6861750/ https://ncbi.nlm.nih.gov/pubmed/31807523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.09.126 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|